F972-0705 Screening compound: N-(3,4-difluorophenyl)-2-{2-[4-(2-methylpropanamido)phenyl]ethyl}-1H-1,3-benzodiazole-5-carboxamide

F972-0705 Screening compound: N-(3,4-difluorophenyl)-2-{2-[4-(2-methylpropanamido)phenyl]ethyl}-1H-1,3-benzodiazole-5-carboxamide
F972-0705 Screening compound: N-(3,4-difluorophenyl)-2-{2-[4-(2-methylpropanamido)phenyl]ethyl}-1H-1,3-benzodiazole-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F972-0705
N-(3,4-difluorophenyl)-2-{2-[4-(2-methylpropanamido)phenyl]ethyl}-1H-1,3-benzodiazole-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F972-0705

Molecular Formula

C26H24F2N4O2 (C26 H24 F2 N4 O2)

Compound Name

N-(3,4-difluorophenyl)-2-{2-[4-(2-methylpropanamido)phenyl]ethyl}-1H-1,3-benzodiazole-5-carboxamide

IUPAC name

N-(34-difluorophenyl)-2-{2-[4-(2-methylpropanamido)phenyl]ethyl}-1H-13-benzodiazole-5-carboxamide

SMILES

CC(C)C(Nc1ccc(CCc2nc(cc(cc3)C(Nc(cc4)cc(F)c4F)=O)c3[nH]2)cc1)=O

InChI

InChI=1S/C26H24F2N4O2/c1-15(2)25(33)29-18-7-3-16(4-8-18)5-12-24-31-22-11-6-17(13-23(22)32-24)26(34)30-19-9-10-20(27)21(28)14-19/h3-4,6-11,13-15H,5,12H2,1-2H3,(H,29,33)(H,30,34)(H,31,32)

InChI Key

GQJCAKWVXFMIQE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27642995

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

462.5

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.489

Distribution Coefficient, logD

5.271

Water Solubility, LogSw

-5.40

Polar Surface Area

66.702

Acid Dissociation Constant (pKa)

7.59

Base Dissociation Constant (pKb)

4.02

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

19.20

F972-0705 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Epigenetics Focused Set (26518 compounds)

New Agro Library (44492 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Agro:
  • Agro
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with F972-0705 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F972-0705?
Check Price and Availability of F972-0705, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F972-0705 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F972-0705
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F972-0705
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F972-0705 available by request